Buckingham Strategic Wealth’s Celgene Corp CELG Stock Holding History
Bought
Maintained
Sold
Other funds holding CELG
FP
HCM
PCMC
WCG
Buckingham Strategic Wealth's CELG Position: Q4 2019 in Review
Buckingham Strategic Wealth sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 2,694 shares — an estimated $268K sold.
Buckingham Strategic Wealth first reported a position in CELG in Q4 2014 and held it in 16 quarters. The position peaked at $449K in Q1 2016. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.
- Buckingham Strategic Wealth reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
- Buckingham Strategic Wealth sold 2,694 Celgene Corp shares in Q4 2019, an estimated $268K.
- Buckingham Strategic Wealth first reported a position in Celgene Corp in Q4 2014 and held it in 16 quarters.
- Buckingham Strategic Wealth's Celgene Corp position peaked at $449K in Q1 2016.
- 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.
Based on Buckingham Strategic Wealth's 13F filing for Q4 2019, filed 4 Feb 2020.